Feedback

Nanocarriers containing platinum compounds for combination chemotherapy

Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Fang, Guihua;
Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Zhang, Aiwen;
Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Zhu, Lu;
Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Wang, Qiuxiang;
Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Sun, Feilong;
Affiliation
School of Pharmacy ,Nantong University ,Nantong ,Jiangsu ,China
Tang, Bo

Platinum compounds-based drugs are used widely in the clinic for the treatment of many types of cancer. However, serious undesirable side effects and intrinsic or acquired resistance limit their successful clinic use. Nanocarrier-based combination chemotherapy is considered to be an effective strategy to resolve these challenges. This review introduces the recent advance in nanocarriers containing platinum compounds for combination cancer chemotherapy, including liposomes, polymer nanoparticles, polymer micelles, mesoporous silica nanoparticles, carbon nanohors, polymer-caged nanobins, carbon nanotube, nanostructured lipid carriers, solid lipid nanoparticles, and multilayered fiber mats in detail.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2022 Fang, Zhang, Zhu, Wang, Sun and Tang.

Use and reproduction: